The invention provides alkyne substituted quinazoline compounds, such as compounds of the formula (I), which are irreversible ErbB kinase inhibitors. The compounds are useful in the treatment of diseases and disorders where ErbB kinase activity is implicated such as a hyperproliferative disorder (e.g., cancer).
本发明提供了烷基取代的
喹唑啉化合物,如式(I)化合物,它们是不可逆的 ErbB 激酶
抑制剂。这些化合物可用于治疗与 ErbB 激酶活性有关的疾病和失调,如过度增殖性失调(如癌症)。